Astragalin mitigates inflammatory osteolysis by negatively modulating osteoclastogenesis via ROS and MAPK signaling pathway
Fangze Xing, Luying Geng, Huanshuai Guan, Donghua Liu, Yiyang Li, Lizhong Zeng, Yang Chen, Run Tian, Zhe Li, Ruomu Cao, Yiwei Zhao, Peng Yan, Hui Qiang, Ning Kong, Kunzheng Wang, Pei Yang
Topics & Concepts
OsteoclastOsteolysisBone resorptionMAPK/ERK pathwayCathepsin KRANKLCancer researchPharmacologyChemistryMedicineSignal transductionInternal medicineActivator (genetics)BiochemistryReceptorSurgeryBone Metabolism and DiseasesBone and Joint DiseasesOsteomyelitis and Bone Disorders Research